Carrus Capital Corporation (Carrus), formerly BioWest Therapeutics Inc., is an investment issuer. Carrus's primary objective is to increase shareholder value through the identification of and investment in securities of publicly listed corporations offering capital appreciation potential. Investments will be acquired and held for both short-term gains and long-term capital appreciation, dependent upon the specific investment. The Company may also invest in private companies. Carrus expects its investment activities will be primarily focused on enterprises located in Canada and the United States, although investments may extend globally, including the purchase of securities listed on foreign stock exchanges. Carrus expects to invest in a range of industries without regard to a specific policy on investment diversification.